José Luis Leal

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

European Cardiovascular Disease Statistics 2017

Elizabeth Wilkins, Lloyd R. Wilson, Kremlin Wickramasinghe et al. · 2017 · 522 citations

Cardiovascular Epidemiology, Cardiovascular Disease, Preventive Cardiology +5

European Cardiovascular Disease Statistics 2012

Melanie Nichols, Nick Townsend, Ramón Luengo-Fernández et al. · 2012 · 380 citations

Hypertension, Cardiovascular Epidemiology, Cardiovascular Disease +7

EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non–Small Cell Lung Cancer

José Luis Leal, Marliese Alexander, Malinda Itchins et al. · Clinical Lung Cancer · 2021 · 36 citations

Insertion Mutations, Medicine, Pathology +9

NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer

José Luis Leal, Geoffrey Peters, Marcin Szaumkessel et al. · Lung Cancer · 2020 · 33 citations

Pulmonary Neuroendocrine Tumours, Malignant Pleural Mesothelioma, Pathology +7